https://www.bloomberg.com/news/articles/2022-10-20/boost-founder-wants-to-buy-back-service-prevent-deal-by-dish#xj4y7vzkg?leadSource=uverify%20wall
Vaxart Touts Encouraging Positive Preliminary Data From Bivalent Norovirus Vaccine Study
Vaxart Inc (NASDAQ: VXRT) announced topline data from the dose-ranging Phase 2 trial of its oral pill